首页 > 最新文献

Ocular Surface最新文献

英文 中文
Diagnostic performance and optimal cut-off values for tear film lipid layer grading and thickness in dry eye disease: An investigator-masked, randomised crossover study 干眼症泪膜脂质层分级和厚度的诊断性能和最佳临界值:一项研究者掩蔽的随机交叉研究。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.09.004
Michael T.M. Wang, Barry Power, Ally L. Xue, Jennifer P. Craig
{"title":"Diagnostic performance and optimal cut-off values for tear film lipid layer grading and thickness in dry eye disease: An investigator-masked, randomised crossover study","authors":"Michael T.M. Wang, Barry Power, Ally L. Xue, Jennifer P. Craig","doi":"10.1016/j.jtos.2024.09.004","DOIUrl":"10.1016/j.jtos.2024.09.004","url":null,"abstract":"","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 415-417"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolomics of basal tears in amyotrophic lateral sclerosis: A cross-sectional study 肌萎缩侧索硬化症患者基底泪液的代谢组学:一项横断面研究。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.09.005
Raoul K. Khanna , Sophie Catanese , Geoffroy Mortemousque , Camille Dupuy , Antoine Lefevre , Patrick Emond , Stéphane Beltran , Valérie Gissot , Pierre-Jean Pisella , Hélène Blasco , Philippe Corcia

Purpose

Amyotrophic lateral sclerosis (ALS) clinical variability, along with the lack of conclusive diagnostic instruments, result in average diagnosis delays of 9 months. This study aimed to assess whether metabolomic profiling of basal tears in ALS patients could act as a biological marker for diagnosing ALS, predicting prognosis, and discriminating between endophenotypes.

Methods

A single-center prospective case-control study was conducted in France from September 2021 to March 2023 including patients with ALS according to the revised EI Escorial criteria. Two microliters of basal tears were collected using microcapillary glass tubes and analyzed with ultra-high performance liquid chromatography coupled with mass spectrometry. Both univariate and multivariate analyses were performed.

Results

Twenty-five patients with ALS and 30 controls were included. No significant differences in metabolite levels were found between ALS and control groups (p > 0.05). The basal tear metabolome significantly discriminated bulbar and spinal forms of ALS based on 6 metabolites, among which 5 were decreased (aniline, trigonelline, caffeine, theophylline and methyl beta-D-galactoside) in the bulbar form and 1 was decreased in the spinal form (dodecanedioic acid).

Conclusion

This study represents the first prospective analysis of basal tear metabolomics in individuals with ALS. Despite the inability to distinguish between ALS patients and controls based on metabolic signatures, these findings could contribute to understanding the phenotypic diversity of ALS. Notably, distinct metabolic profiles were identified that differentiate between the bulbar and spinal forms of the disease.
目的:肌萎缩性脊髓侧索硬化症(ALS)临床表现多变,加上缺乏确凿的诊断工具,导致平均诊断延迟9个月。本研究旨在评估 ALS 患者基底泪液的代谢组学分析是否可作为诊断 ALS、预测预后和区分内分型的生物标记物:方法:2021 年 9 月至 2023 年 3 月在法国开展了一项单中心前瞻性病例对照研究,根据修订后的 EI Escorial 标准纳入 ALS 患者。研究人员使用微毛细管玻璃管收集了两微升的基础泪液,并使用超高效液相色谱法和质谱法进行了分析。进行了单变量和多变量分析:结果:共纳入 25 名 ALS 患者和 30 名对照组。ALS 组和对照组的代谢物水平无明显差异(P>0.05)。基础泪液代谢组中的 6 种代谢物可明显区分脊髓侧索硬化症的球部和脊柱型,其中球部型患者的 5 种代谢物(苯胺、三尖杉碱、咖啡因、茶碱和甲基 beta-D-半乳糖苷)含量降低,脊柱型患者的 1 种代谢物(十二碳二酸)含量降低:这项研究首次对 ALS 患者的基础泪液代谢组学进行了前瞻性分析。尽管无法根据代谢特征区分 ALS 患者和对照组,但这些发现有助于了解 ALS 的表型多样性。值得注意的是,研究还发现了区分脊髓侧索硬化症和球部侧索硬化症的不同代谢特征。
{"title":"Metabolomics of basal tears in amyotrophic lateral sclerosis: A cross-sectional study","authors":"Raoul K. Khanna ,&nbsp;Sophie Catanese ,&nbsp;Geoffroy Mortemousque ,&nbsp;Camille Dupuy ,&nbsp;Antoine Lefevre ,&nbsp;Patrick Emond ,&nbsp;Stéphane Beltran ,&nbsp;Valérie Gissot ,&nbsp;Pierre-Jean Pisella ,&nbsp;Hélène Blasco ,&nbsp;Philippe Corcia","doi":"10.1016/j.jtos.2024.09.005","DOIUrl":"10.1016/j.jtos.2024.09.005","url":null,"abstract":"<div><h3>Purpose</h3><div>Amyotrophic lateral sclerosis (ALS) clinical variability, along with the lack of conclusive diagnostic instruments, result in average diagnosis delays of 9 months. This study aimed to assess whether metabolomic profiling of basal tears in ALS patients could act as a biological marker for diagnosing ALS, predicting prognosis, and discriminating between endophenotypes.</div></div><div><h3>Methods</h3><div>A single-center prospective case-control study was conducted in France from September 2021 to March 2023 including patients with ALS according to the revised EI Escorial criteria. Two microliters of basal tears were collected using microcapillary glass tubes and analyzed with ultra-high performance liquid chromatography coupled with mass spectrometry. Both univariate and multivariate analyses were performed.</div></div><div><h3>Results</h3><div>Twenty-five patients with ALS and 30 controls were included. No significant differences in metabolite levels were found between ALS and control groups (p &gt; 0.05). The basal tear metabolome significantly discriminated bulbar and spinal forms of ALS based on 6 metabolites, among which 5 were decreased (aniline, trigonelline, caffeine, theophylline and methyl beta-D-galactoside) in the bulbar form and 1 was decreased in the spinal form (dodecanedioic acid).</div></div><div><h3>Conclusion</h3><div>This study represents the first prospective analysis of basal tear metabolomics in individuals with ALS. Despite the inability to distinguish between ALS patients and controls based on metabolic signatures, these findings could contribute to understanding the phenotypic diversity of ALS. Notably, distinct metabolic profiles were identified that differentiate between the bulbar and spinal forms of the disease.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 363-369"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simple limbal epithelial transplantation versus cultivated limbal epithelial transplantation in ocular burns 眼烧伤中的单纯角膜缘上皮移植与角膜缘上皮培养移植。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.10.007
Namrata Sharma , Renu Venugopal , Sujata Mohanty , K. Priyadarshini , Ritu Nagpal , Deepali Singhal , Aafreen Bari , Tanuj Dada , Prafulla Kumar Maharana , Tushar Agarwal , Ashish Dutt Upadhyay

Purpose

To compare the outcomes of simple limbal epithelial transplantation (SLET) with cultivated limbal epithelial transplantation (CLET) for the management of total limbal stem cell deficiency (LSCD) in eyes with unilateral ocular burns.

Design

Randomized controlled trial.

Methods

100 patients (100 eyes) with unilateral total LSCD following ocular burns undergoing autologous Limbal Stem Cell Transplantation (LSCT) were enrolled and randomized into SLET and CLET groups. Restoration of an epithelized ocular surface was the primary outcome measure. Occurrences of progressive conjunctivalization and persistent epithelial defects postoperatively were considered surgical failures.

Results

Mean age was 20.2 ± 13.1 years (SLET) and 22.6 ± 14.3 years (CLET) (p = 0.363). Alkali burn was the most common causative factor in both groups and had comparable mean logMAR BCVA at presentation [SLET: 2.33 ± 0.5, CLET: 2.23 ± 1.48 (p = 0.652)]. Median time interval between injury and surgical intervention was 18 months (SLET) and 12 months (CLET) (p = 0.06). 88 % eyes in SLET group maintained a stable ocular surface at 1 year period versus CLET group (86 %) (p = 0.999). Mean logMAR BCVA significantly improved in both groups with SLET having significantly better BCVA versus CLET at 6 months (p = 0.0390), 1 year (p = 0.0001), 2 year (p = 0.0001) and 3 years (p = 0.0001) follow up. Kaplan-Meier survival analysis was statistically insignificant amongst the 2 groups (p = 0.590).

Conclusions

Compared to CLET, SLET is equally efficacious in restoring and maintaining a stable ocular surface in eyes with total LSCD due to ocular burns, with the added advantage of providing superior visual outcomes.
目的:比较单纯瓣上皮移植术(SLET)和培养瓣上皮移植术(CLET)治疗单侧眼烧伤后全瓣干细胞缺乏症(LSCD)的疗效:随机对照试验。方法:100 名眼部烧伤后单侧全缘干细胞缺乏症患者(100 只眼)接受自体眼缘干细胞移植术(LSCT),并随机分为 SLET 组和 CLET 组。恢复上皮化的眼表是衡量疗效的主要指标。术后出现进行性结膜化和持续性上皮缺损被视为手术失败:平均年龄为 20.2 ± 13.1 岁(SLET)和 22.6 ± 14.3 岁(CLET)(p = 0.363)。碱烧伤是两组患者最常见的致病因素,两组患者发病时的 BCVA 平均对数值相当[SLET:2.33 ± 0.5,CLET:2.23 ± 1.48 (p = 0.652)]。从受伤到手术干预的中位时间间隔为 18 个月(SLET)和 12 个月(CLET)(p = 0.06)。SLET组88%的眼睛在1年后眼表保持稳定,而CLET组为86%(p = 0.999)。两组患者的 BCVA 平均对数均有显著改善,SLET 组在 6 个月(p = 0.0390)、1 年(p = 0.0001)、2 年(p = 0.0001)和 3 年(p = 0.0001)随访期间的 BCVA 均明显优于 CLET 组。Kaplan-Meier生存率分析结果显示,两组间差异无统计学意义(p = 0.590):结论:与 CLET 相比,SLET 在恢复和维持因眼部烧伤导致的全 LSCD 眼的眼表稳定方面同样有效,而且还具有视觉效果更佳的优势。
{"title":"Simple limbal epithelial transplantation versus cultivated limbal epithelial transplantation in ocular burns","authors":"Namrata Sharma ,&nbsp;Renu Venugopal ,&nbsp;Sujata Mohanty ,&nbsp;K. Priyadarshini ,&nbsp;Ritu Nagpal ,&nbsp;Deepali Singhal ,&nbsp;Aafreen Bari ,&nbsp;Tanuj Dada ,&nbsp;Prafulla Kumar Maharana ,&nbsp;Tushar Agarwal ,&nbsp;Ashish Dutt Upadhyay","doi":"10.1016/j.jtos.2024.10.007","DOIUrl":"10.1016/j.jtos.2024.10.007","url":null,"abstract":"<div><h3>Purpose</h3><div>To compare the outcomes of simple limbal epithelial transplantation (SLET) with cultivated limbal epithelial transplantation (CLET) for the management of total limbal stem cell deficiency (LSCD) in eyes with unilateral ocular burns.</div></div><div><h3>Design</h3><div>Randomized controlled trial.</div></div><div><h3>Methods</h3><div>100 patients (100 eyes) with unilateral total LSCD following ocular burns undergoing autologous Limbal Stem Cell Transplantation (LSCT) were enrolled and randomized into SLET and CLET groups. Restoration of an epithelized ocular surface was the primary outcome measure. Occurrences of progressive conjunctivalization and persistent epithelial defects postoperatively were considered surgical failures.</div></div><div><h3>Results</h3><div>Mean age was 20.2 ± 13.1 years (SLET) and 22.6 ± 14.3 years (CLET) (p = 0.363). Alkali burn was the most common causative factor in both groups and had comparable mean logMAR BCVA at presentation [SLET: 2.33 ± 0.5, CLET: 2.23 ± 1.48 (p = 0.652)]. Median time interval between injury and surgical intervention was 18 months (SLET) and 12 months (CLET) (p = 0.06). 88 % eyes in SLET group maintained a stable ocular surface at 1 year period versus CLET group (86 %) (p = 0.999). Mean logMAR BCVA significantly improved in both groups with SLET having significantly better BCVA versus CLET at 6 months (p = 0.0390), 1 year (p = 0.0001), 2 year (p = 0.0001) and 3 years (p = 0.0001) follow up. Kaplan-Meier survival analysis was statistically insignificant amongst the 2 groups (p = 0.590).</div></div><div><h3>Conclusions</h3><div>Compared to CLET, SLET is equally efficacious in restoring and maintaining a stable ocular surface in eyes with total LSCD due to ocular burns, with the added advantage of providing superior visual outcomes.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 504-509"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Target specification and therapeutic potential of extracellular vesicles for regulating corneal angiogenesis, lymphangiogenesis, and nerve repair 细胞外囊泡在调节角膜血管生成、淋巴管生成和神经修复方面的靶标定位和治疗潜力。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.10.005
Cameron Pedersen , Victoria T. Chen , Paula Herbst , Runze Zhang , Amr Elfert , Abhi Krishan , Dimitri T. Azar , Jin-Hong Chang , Wen-Yang Hu , Tobias P. Kremsmayer , Elmira Jalilian , Ali R. Djalilian , Victor H. Guaiquil , Mark I. Rosenblatt
Extracellular vesicles, including exosomes, are small extracellular vesicles that range in size from 30 nm to 10 μm in diameter and have specific membrane markers. They are naturally secreted and are present in various bodily fluids, including blood, urine, and saliva, and through the variety of their internal cargo, they contribute to both normal physiological and pathological processes. These processes include immune modulation, neuronal synapse formation, cell differentiation, cancer metastasis, angiogenesis, lymphangiogenesis, progression of infectious disease, and neurodegenerative disorders like Alzheimer's and Parkinson's disease. In recent years, interest has grown in the use of exosomes as a potential drug delivery system for various diseases and injuries. Importantly, exosomes originating from a patient's own cells exhibit minimal immunogenicity and possess remarkable stability along with inherent and adjustable targeting capabilities. This review explores the roles of exosomes in angiogenesis, lymphangiogenesis, and nerve repair with a specific emphasis on these processes within the cornea. Furthermore, it examines exosomes derived from specific cell types, discusses the advantages of exosome-based therapies in modulating these processes, and presents some of the most established methods for exosome isolation. Exosome-based treatments are emerging as potential minimally invasive and non-immunogenic therapies that modulate corneal angiogenesis and lymphangiogenesis, as well as enhance and accelerate endogenous corneal nerve repair.
细胞外囊泡,包括外泌体,是一种小的细胞外囊泡,直径从 30 纳米到 10 微米不等,具有特定的膜标记。它们是自然分泌的,存在于血液、尿液和唾液等各种体液中,通过其内部货物的多样性,它们对正常的生理和病理过程都有贡献。这些过程包括免疫调节、神经元突触形成、细胞分化、癌症转移、血管生成、淋巴管生成、传染病进展以及阿尔茨海默氏症和帕金森氏症等神经退行性疾病。近年来,人们对外泌体作为一种潜在的药物输送系统用于治疗各种疾病和损伤的兴趣与日俱增。重要的是,源于患者自身细胞的外泌体具有极低的免疫原性、出色的稳定性以及固有的可调节靶向能力。本综述探讨了外泌体在血管生成、淋巴管生成和神经修复中的作用,并特别强调了角膜中的这些过程。此外,它还研究了从特定细胞类型中提取的外泌体,讨论了基于外泌体的疗法在调节这些过程中的优势,并介绍了一些最成熟的外泌体分离方法。基于外泌体的疗法正在成为潜在的微创、非免疫原性疗法,可调节角膜血管生成和淋巴管生成,并增强和加速内源性角膜神经修复。
{"title":"Target specification and therapeutic potential of extracellular vesicles for regulating corneal angiogenesis, lymphangiogenesis, and nerve repair","authors":"Cameron Pedersen ,&nbsp;Victoria T. Chen ,&nbsp;Paula Herbst ,&nbsp;Runze Zhang ,&nbsp;Amr Elfert ,&nbsp;Abhi Krishan ,&nbsp;Dimitri T. Azar ,&nbsp;Jin-Hong Chang ,&nbsp;Wen-Yang Hu ,&nbsp;Tobias P. Kremsmayer ,&nbsp;Elmira Jalilian ,&nbsp;Ali R. Djalilian ,&nbsp;Victor H. Guaiquil ,&nbsp;Mark I. Rosenblatt","doi":"10.1016/j.jtos.2024.10.005","DOIUrl":"10.1016/j.jtos.2024.10.005","url":null,"abstract":"<div><div>Extracellular vesicles, including exosomes, are small extracellular vesicles that range in size from 30 nm to 10 μm in diameter and have specific membrane markers. They are naturally secreted and are present in various bodily fluids, including blood, urine, and saliva, and through the variety of their internal cargo, they contribute to both normal physiological and pathological processes. These processes include immune modulation, neuronal synapse formation, cell differentiation, cancer metastasis, angiogenesis, lymphangiogenesis, progression of infectious disease, and neurodegenerative disorders like Alzheimer's and Parkinson's disease. In recent years, interest has grown in the use of exosomes as a potential drug delivery system for various diseases and injuries. Importantly, exosomes originating from a patient's own cells exhibit minimal immunogenicity and possess remarkable stability along with inherent and adjustable targeting capabilities. This review explores the roles of exosomes in angiogenesis, lymphangiogenesis, and nerve repair with a specific emphasis on these processes within the cornea. Furthermore, it examines exosomes derived from specific cell types, discusses the advantages of exosome-based therapies in modulating these processes, and presents some of the most established methods for exosome isolation. Exosome-based treatments are emerging as potential minimally invasive and non-immunogenic therapies that modulate corneal angiogenesis and lymphangiogenesis, as well as enhance and accelerate endogenous corneal nerve repair.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 459-476"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing and treating neurotrophic keratopathy by a single intrastromal injection of AAV-mediated gene therapy 通过一次性腹腔注射 AAV 介导的基因疗法预防和治疗神经营养性角膜病。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.09.010
Lin Cong , Benxiang Qi , Wenhui Ma , Zhongmei Ren , Qian Liang , Qingjun Zhou , Bi Ning Zhang , Lixin Xie

Purpose

Neurotrophic keratopathy (NK) is a degenerative corneal condition resulting from corneal nerve injury. Current therapies, including the recombinant human nerve growth factor (rhNGF) therapy, requires continuous administration. This study aims to develop a novel and highly effective gene therapy strategy for the prevention and treatment of NK.

Methods

Adeno-associated virus (AAV) was transduced into corneal stromal cells by intrastromal injection. Three dimensional corneal wholemount imaging with co-immunostaining of ZO-1 and tubulin was utilized to assess the transduction of AAV.rh10. The efficacy of prevention and treatment of NK by a single intrastromal injection of AAV-Ngf was tested using capsaicin mouse model, herpes simplex keratitis (HSK) model, type Ⅱ diabetes model and alkali burn model. rhNGF eye drops served as the positive control.

Results

Intrastromal injection of AAV.rh10 efficiently transduced the subepithelial nerve plexus and retrogradely transported to the trigeminal ganglion (TG). A single injection of AAV.rh10-Ngf can significantly promote corneal nerve repair, accelerate corneal epithelial repair, reduce corneal stromal edema, and improve corneal sensitivity across the four NK models. The therapeutic effects were consistent with those achieved by continuous administration of rhNGF drops by 6 times daily.

Conclusions

This proof-of-concept study demonstrates that AAV.rh10-Ngf gene therapy is a promising method for preventing and treating of NK. Our results underline the potential for developing clinical trials to further explore the safety and efficacy of such gene therapy.
目的:神经营养性角膜病(NK)是一种由角膜神经损伤引起的角膜退行性病变。目前的疗法,包括重组人神经生长因子(rhNGF)疗法,需要持续给药。本研究旨在开发一种预防和治疗 NK 的新型高效基因治疗策略:方法:通过基质内注射将腺相关病毒(AAV)转入角膜基质细胞。方法:将腺相关病毒(AAV)通过基质内注射转导到角膜基质细胞中,利用三维角膜全层成像和 ZO-1 与微管蛋白的联合免疫染色来评估 AAV.rh10 的转导情况。在辣椒素小鼠模型、单纯疱疹性角膜炎(HSK)模型、Ⅱ型糖尿病模型和碱烧伤模型中测试了一次性鞘内注射 AAV-Ngf 预防和治疗 NK 的疗效,rhNGF 滴眼液作为阳性对照:结果:AAV.rh10的鞘内注射能有效转导上皮下神经丛,并逆行转运至三叉神经节(TG)。在四种 NK 模型中,单次注射 AAV.rh10-Ngf 可显著促进角膜神经修复、加速角膜上皮修复、减轻角膜基质水肿并提高角膜敏感性。这些治疗效果与每日6次持续滴注rhNGF所取得的效果一致:这项概念验证研究表明,AAV.rh10-Ngf 基因疗法是一种预防和治疗 NK 的有效方法。我们的研究结果凸显了开展临床试验以进一步探索此类基因疗法的安全性和有效性的潜力。
{"title":"Preventing and treating neurotrophic keratopathy by a single intrastromal injection of AAV-mediated gene therapy","authors":"Lin Cong ,&nbsp;Benxiang Qi ,&nbsp;Wenhui Ma ,&nbsp;Zhongmei Ren ,&nbsp;Qian Liang ,&nbsp;Qingjun Zhou ,&nbsp;Bi Ning Zhang ,&nbsp;Lixin Xie","doi":"10.1016/j.jtos.2024.09.010","DOIUrl":"10.1016/j.jtos.2024.09.010","url":null,"abstract":"<div><h3>Purpose</h3><div>Neurotrophic keratopathy (NK) is a degenerative corneal condition resulting from corneal nerve injury. Current therapies, including the recombinant human nerve growth factor (rhNGF) therapy, requires continuous administration. This study aims to develop a novel and highly effective gene therapy strategy for the prevention and treatment of NK.</div></div><div><h3>Methods</h3><div>Adeno-associated virus (AAV) was transduced into corneal stromal cells by intrastromal injection. Three dimensional corneal wholemount imaging with co-immunostaining of ZO-1 and tubulin was utilized to assess the transduction of AAV.rh10. The efficacy of prevention and treatment of NK by a single intrastromal injection of AAV-Ngf was tested using capsaicin mouse model, herpes simplex keratitis (HSK) model, type Ⅱ diabetes model and alkali burn model. rhNGF eye drops served as the positive control.</div></div><div><h3>Results</h3><div>Intrastromal injection of AAV.rh10 efficiently transduced the subepithelial nerve plexus and retrogradely transported to the trigeminal ganglion (TG). A single injection of AAV.rh10-Ngf can significantly promote corneal nerve repair, accelerate corneal epithelial repair, reduce corneal stromal edema, and improve corneal sensitivity across the four NK models. The therapeutic effects were consistent with those achieved by continuous administration of rhNGF drops by 6 times daily.</div></div><div><h3>Conclusions</h3><div>This proof-of-concept study demonstrates that AAV.rh10-Ngf gene therapy is a promising method for preventing and treating of NK. Our results underline the potential for developing clinical trials to further explore the safety and efficacy of such gene therapy.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 406-414"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Readership awareness series – paper 14: The submission Dilemma - How to choose a journal? 读者意识丛书--论文 14:投稿困境--如何选择期刊?
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.11.003
Mohammad Javed Ali, Ali Djalilian
{"title":"Readership awareness series – paper 14: The submission Dilemma - How to choose a journal?","authors":"Mohammad Javed Ali,&nbsp;Ali Djalilian","doi":"10.1016/j.jtos.2024.11.003","DOIUrl":"10.1016/j.jtos.2024.11.003","url":null,"abstract":"","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 521-522"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytarabine chemotherapy induces meibomian gland dysfunction 阿糖胞苷化疗诱发睑板腺功能障碍
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.10.002
Ren Liu , Jianwen Xue , Jiaxu Han, Mengqian Tu, Wenhui Wang, Ziyan Chen, Xiaobing Qian, Bing Xiao, Lingyi Liang

Purpose

Cytarabine (Ara-C) chemotherapy causes symptoms resembling meibomian gland dysfunction (MGD), suggesting potential associations between Ara-C and MGD. In this study, the pathological effects of Ara-C on MGD were investigated in a rodent model.

Methods

Mice received Ara-C with or without rosiglitazone (PPARγ agonist) for 7 consecutive days. Slit-lamp biomicroscope was used for ocular examinations. Immunofluorescence detected acinar cell proliferation, differentiation, and ductal keratinization in the meibomian gland (MG). Lipid accumulation was evaluated by Oil Red O and LipidTox staining. Lipogenic status, FoxO1/FoxO3a cellular localization, and oxidative stress were visualized via immunohistochemistry. Western blotting assessed relative protein expression and AKT/FoxO1/FoxO3a pathway phosphorylation.

Results

Ara-C (50 mg/kg) did not affect mouse survival but induced damage to ocular surface microenvironment, including corneal epithelial defects, MG orifice plugging and acinar dropout, and lacrimal gland (LG) dysfunction. Ara-C intervention inhibited proliferation and caused progenitor loss in the MG, as evidenced by reduced PCNA + labeling and P63+/Lrig1+ basal cell numbers. The MG ducts of Ara-C-treated mice exhibited marked dilatation, lipid deposition, and hyperkeratinization (K1/K10 overexpression). Ara-C disrupted MG lipid metabolism by downregulating PPARγ and its downstream lipogenic targets AWAT2/SOAT1/ELOVL4 and upregulating HMGCR. Dephosphorylation of AKT and the subsequent nuclear translocation of FoxO1/FoxO3a contributed to Ara-C-induced PPARγ downregulation. Ara-C triggered oxidative stress with increases in 4-HNE and 8-OHdG and Keap1/Nrf2/HO-1/SOD1 axis dysregulation. Rosiglitazone treatment ameliorated MGD-associated pathological manifestations, LG function, MG lipid metabolism, and oxidative stress in Ara-C-exposed mice.

Conclusions

Systemic Ara-C chemotherapy exerted topical cytotoxic effects on the ocular surface, and PPARγ restoration by rosiglitazone mitigated Ara-C-induced MGD alterations.
目的阿糖胞苷(Ara-C)化疗会导致类似睑板腺功能障碍(MGD)的症状,这表明 Ara-C 和 MGD 之间可能存在关联。本研究在啮齿动物模型中研究了 Ara-C 对 MGD 的病理影响。使用裂隙灯生物显微镜进行眼部检查。免疫荧光检测睑板腺(MG)中的尖状细胞增殖、分化和导管角化。油红 O 和脂毒染色法评估了脂质积累情况。通过免疫组化观察生脂状态、FoxO1/FoxO3a细胞定位和氧化应激。结果 Ara-C(50 毫克/千克)不影响小鼠的存活率,但会导致眼表微环境受损,包括角膜上皮缺损、MG 口堵塞和尖锐湿疣脱落以及泪腺(LG)功能障碍。Ara-C干预抑制了MG的增殖并导致祖细胞丢失,PCNA+标记和P63+/Lrig1+基底细胞数量的减少证明了这一点。经 Ara-C 处理的小鼠的 MG 管表现出明显的扩张、脂质沉积和过度角质化(K1/K10 过度表达)。Ara-C 通过下调 PPARγ 及其下游致脂靶标 AWAT2/SOAT1/ELOVL4 和上调 HMGCR 破坏了 MG 的脂质代谢。AKT 的去磷酸化和随后 FoxO1/FoxO3a 的核转位有助于 Ara-C 诱导的 PPARγ 下调。Ara-C 引发氧化应激,导致 4-HNE 和 8-OHdG 增加,Keap1/Nrf2/HO-1/SOD1 轴失调。结论 系统性 Ara-C 化疗对眼表产生局部细胞毒性作用,罗格列酮对 PPARγ 的恢复减轻了 Ara-C 诱导的 MGD 改变。
{"title":"Cytarabine chemotherapy induces meibomian gland dysfunction","authors":"Ren Liu ,&nbsp;Jianwen Xue ,&nbsp;Jiaxu Han,&nbsp;Mengqian Tu,&nbsp;Wenhui Wang,&nbsp;Ziyan Chen,&nbsp;Xiaobing Qian,&nbsp;Bing Xiao,&nbsp;Lingyi Liang","doi":"10.1016/j.jtos.2024.10.002","DOIUrl":"10.1016/j.jtos.2024.10.002","url":null,"abstract":"<div><h3>Purpose</h3><div>Cytarabine (Ara-C) chemotherapy causes symptoms resembling meibomian gland dysfunction (MGD), suggesting potential associations between Ara-C and MGD. In this study, the pathological effects of Ara-C on MGD were investigated in a rodent model.</div></div><div><h3>Methods</h3><div>Mice received Ara-C with or without rosiglitazone (PPARγ agonist) for 7 consecutive days. Slit-lamp biomicroscope was used for ocular examinations. Immunofluorescence detected acinar cell proliferation, differentiation, and ductal keratinization in the meibomian gland (MG). Lipid accumulation was evaluated by Oil Red O and LipidTox staining. Lipogenic status, FoxO1/FoxO3a cellular localization, and oxidative stress were visualized via immunohistochemistry. Western blotting assessed relative protein expression and AKT/FoxO1/FoxO3a pathway phosphorylation.</div></div><div><h3>Results</h3><div>Ara-C (50 mg/kg) did not affect mouse survival but induced damage to ocular surface microenvironment, including corneal epithelial defects, MG orifice plugging and acinar dropout, and lacrimal gland (LG) dysfunction. Ara-C intervention inhibited proliferation and caused progenitor loss in the MG, as evidenced by reduced PCNA + labeling and P63+/Lrig1+ basal cell numbers. The MG ducts of Ara-C-treated mice exhibited marked dilatation, lipid deposition, and hyperkeratinization (K1/K10 overexpression). Ara-C disrupted MG lipid metabolism by downregulating PPARγ and its downstream lipogenic targets AWAT2/SOAT1/ELOVL4 and upregulating HMGCR. Dephosphorylation of AKT and the subsequent nuclear translocation of FoxO1/FoxO3a contributed to Ara-C-induced PPARγ downregulation. Ara-C triggered oxidative stress with increases in 4-HNE and 8-OHdG and Keap1/Nrf2/HO-1/SOD1 axis dysregulation. Rosiglitazone treatment ameliorated MGD-associated pathological manifestations, LG function, MG lipid metabolism, and oxidative stress in Ara-C-exposed mice.</div></div><div><h3>Conclusions</h3><div>Systemic Ara-C chemotherapy exerted topical cytotoxic effects on the ocular surface, and PPARγ restoration by rosiglitazone mitigated Ara-C-induced MGD alterations.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 444-458"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blinded by smoke: Wildfire smoke exposure and eye irritation in australian wildland firefighters 烟雾致盲:澳大利亚野地消防员的野火烟雾暴露和眼部刺激。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.09.001
Sukanya Jaiswal , Isabelle Jalbert , Nicholas Olsen , Anthea Burnett , Blanka Golebiowski

Purpose

Wildfire occurrence is increasing worldwide, putting firefighters and general public at increased risk of eye injuries from smoke exposure. This study explored ocular symptoms and use of protective eyewear amongst wildland firefighters in Australia.

Methods

Australian wildland firefighters were invited to complete an online survey about the occurrence of eye irritation, use of protective eyewear and behaviours associated with occupational smoke exposure. Responses were analysed using logistic regression and qualitative inductive content analysis.

Results

338 wildland firefighters completed the survey. Eye irritation was reported by 90 % of firefighters at least sometimes during work and by 70 % after work. Frequency of eye irritation was greater amongst females than males (OR 2.01, CI 1.22–3.31, p < 0.001). Protective eyewear was used often or always by 67 % of firefighters on the fireground, however 55 % had to remove their protective eyewear due to sweat, fogging or another reason. Goggles were more likely to be removed compared to sunglasses and safety glasses (OR 4.28, CI 2.75–6.68, p < 0.001).
Firefighters reported that, at times smoke exposure necessitated eye closure and impaired vision on the fireground. Firefighters also reported that protective eyewear helped to reduce eye symptoms, but its consistent use on the fireground was difficult. The severity and recovery from eye symptoms varied between participants.

Conclusion

Australian wildland firefighters frequently experience eye irritation from smoke exposure, and this can affect operational capabilities. These findings can support the development of evidence-based strategies to help protect and aid recovery of the eye surface following smoke exposure.
目的:世界各地发生的野火越来越多,消防员和普通公众因暴露在烟雾中而受到眼睛伤害的风险也越来越大。本研究探讨了澳大利亚野外消防员的眼部症状和防护眼镜的使用情况:方法:邀请澳大利亚野外消防员完成一项在线调查,内容涉及眼部刺激的发生、防护眼镜的使用以及与职业烟雾暴露相关的行为。采用逻辑回归和定性归纳内容分析法对回答进行了分析:结果:338 名野外消防员完成了调查。90%的消防员表示至少有时在工作期间和 70% 的消防员在下班后眼睛受到刺激。女性受到眼睛刺激的频率高于男性(OR 2.01,CI 1.22 - 3.31,p):澳大利亚野地消防员经常会因暴露于烟雾中而感到眼睛不适,这可能会影响他们的工作能力。这些发现有助于制定以证据为基础的策略,以帮助保护和帮助烟雾暴露后的眼表恢复。
{"title":"Blinded by smoke: Wildfire smoke exposure and eye irritation in australian wildland firefighters","authors":"Sukanya Jaiswal ,&nbsp;Isabelle Jalbert ,&nbsp;Nicholas Olsen ,&nbsp;Anthea Burnett ,&nbsp;Blanka Golebiowski","doi":"10.1016/j.jtos.2024.09.001","DOIUrl":"10.1016/j.jtos.2024.09.001","url":null,"abstract":"<div><h3>Purpose</h3><div>Wildfire occurrence is increasing worldwide, putting firefighters and general public at increased risk of eye injuries from smoke exposure. This study explored ocular symptoms and use of protective eyewear amongst wildland firefighters in Australia.</div></div><div><h3>Methods</h3><div>Australian wildland firefighters were invited to complete an online survey about the occurrence of eye irritation, use of protective eyewear and behaviours associated with occupational smoke exposure. Responses were analysed using logistic regression and qualitative inductive content analysis.</div></div><div><h3>Results</h3><div>338 wildland firefighters completed the survey. Eye irritation was reported by 90 % of firefighters at least <em>sometimes</em> during work and by 70 % after work. Frequency of eye irritation was greater amongst females than males (OR 2.01, CI 1.22–3.31, p &lt; 0.001). Protective eyewear was used <em>often</em> or <em>always</em> by 67 % of firefighters on the fireground, however 55 % had to remove their protective eyewear due to sweat, fogging or another reason. Goggles were more likely to be removed compared to sunglasses and safety glasses (OR 4.28, CI 2.75–6.68, p &lt; 0.001).</div><div>Firefighters reported that, at times smoke exposure necessitated eye closure and impaired vision on the fireground. Firefighters also reported that protective eyewear helped to reduce eye symptoms, but its consistent use on the fireground was difficult. The severity and recovery from eye symptoms varied between participants.</div></div><div><h3>Conclusion</h3><div>Australian wildland firefighters frequently experience eye irritation from smoke exposure, and this can affect operational capabilities. These findings can support the development of evidence-based strategies to help protect and aid recovery of the eye surface following smoke exposure.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 381-391"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When noise becomes signal: A study of blink rate using an eye tracker 当噪音变成信号:使用眼球跟踪器对眨眼率的研究。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.11.002
Krishnaveni Nagarajan , Kavya Ravi , Shakthi Pradheepa Periakaruppan , PremNandhini Satgunam

Purpose

Although blink rate is considered important for digital eye strain and dry eye conditions, its assessment has been mostly manual. This study aimed at quantifying blink rate automatically using the Eyelink 1000 Plus eye tracker and comparing it with manual counting. Additionally, blink rate was correlated with reading eye movements and reading speed.

Methods

Thirty participants (mean age 26.8 ± 3.5 years; 19 females) were enrolled. An on-screen reading task for 3 min duration, was repeated 3 times with a 2-min break between the repetitions. During this task, eye movements and blinks were measured through the Eyelink 1000 Plus eye tracker. The blink was also counted manually by the examiner in real time from a video feed.

Results

The blink rate obtained by the eye tracker (median [Q1, Q3]:11.7 [6.8,15.5] blinks/min) and manual counting (11.6 [7.1, 15.4] blinks/min) were comparable (p > 0.5). No significant correlations were observed between the blink rate and any of the reading eye movement parameters except saccadic amplitude (Spearman's rho, rs = 0.506). No statistically significant correlation was found between the blink rate and reading speed.

Conclusion

The Eyelink 1000 Plus eye tracker gives a comparable blink rate compared to that obtained through manual counting. A positive correlation between the blink rate and saccade amplitude could indicate a coupled interaction between the two mechanisms to minimize visual loss during reading. The option of using this tracker to investigate blinks in dry eye and binocular vision disorders can be further explored.
目的:虽然眨眼率被认为对数码眼疲劳和干眼症很重要,但其评估大多采用人工方式。本研究旨在使用 Eyelink 1000 Plus 眼动仪自动量化眨眼率,并与人工计数进行比较。此外,眨眼率还与阅读时的眼球运动和阅读速度相关:方法:共招募了 30 名参与者(平均年龄为 26.8±3.5 岁;19 名女性)。屏幕阅读任务持续 3 分钟,重复 3 次,每次之间休息 2 分钟。任务期间,通过 Eyelink 1000 Plus 眼动仪测量眼球运动和眨眼情况。眨眼次数也由检查员通过视频实时手动计数:结果:眼球跟踪仪(中位数[Q1, Q3]:11.7 [6.8, 15.5]次/分钟)和人工计数(11.6 [7.1, 15.4]次/分钟)得出的眨眼率相当(P>0.5)。眨眼次数与任何阅读眼动参数之间都没有明显的相关性,但眼球回转幅度除外(Spearman's rho,rs =0.506)。眨眼次数与阅读速度之间没有统计学意义上的相关性:结论:Eyelink 1000 Plus 眼动仪的眨眼率与人工计数的眨眼率相当。眨眼率与囊状移动幅度之间的正相关可能表明这两种机制之间存在耦合互动,从而最大限度地减少阅读过程中的视觉损失。还可以进一步探索使用这种跟踪器来研究干眼症和双眼视力障碍患者的眨眼情况。
{"title":"When noise becomes signal: A study of blink rate using an eye tracker","authors":"Krishnaveni Nagarajan ,&nbsp;Kavya Ravi ,&nbsp;Shakthi Pradheepa Periakaruppan ,&nbsp;PremNandhini Satgunam","doi":"10.1016/j.jtos.2024.11.002","DOIUrl":"10.1016/j.jtos.2024.11.002","url":null,"abstract":"<div><h3>Purpose</h3><div>Although blink rate is considered important for digital eye strain and dry eye conditions, its assessment has been mostly manual. This study aimed at quantifying blink rate automatically using the Eyelink 1000 Plus eye tracker and comparing it with manual counting. Additionally, blink rate was correlated with reading eye movements and reading speed.</div></div><div><h3>Methods</h3><div>Thirty participants (mean age 26.8 ± 3.5 years; 19 females) were enrolled. An on-screen reading task for 3 min duration, was repeated 3 times with a 2-min break between the repetitions. During this task, eye movements and blinks were measured through the Eyelink 1000 Plus eye tracker. The blink was also counted manually by the examiner in real time from a video feed.</div></div><div><h3>Results</h3><div>The blink rate obtained by the eye tracker (median [Q1, Q3]:11.7 [6.8,15.5] blinks/min) and manual counting (11.6 [7.1, 15.4] blinks/min) were comparable (p &gt; 0.5). No significant correlations were observed between the blink rate and any of the reading eye movement parameters except saccadic amplitude (Spearman's rho, r<sub>s</sub> = 0.506). No statistically significant correlation was found between the blink rate and reading speed.</div></div><div><h3>Conclusion</h3><div>The Eyelink 1000 Plus eye tracker gives a comparable blink rate compared to that obtained through manual counting. A positive correlation between the blink rate and saccade amplitude could indicate a coupled interaction between the two mechanisms to minimize visual loss during reading. The option of using this tracker to investigate blinks in dry eye and binocular vision disorders can be further explored.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 516-520"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Big-bubble DALK: A technique in evolution 大气泡 DALK:进化中的一种技术。
IF 5.9 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.jtos.2024.10.001
Antonio Moramarco , Lorenzo Gardini , Ilaria Di Mola , Natalie di Geronimo , Danilo Iannetta , Vito Romano , Sadeer B. Hannush , Luigi Fontana
Deep anterior lamellar keratoplasty (DALK) is considered a valuablealternative to penetrating keratoplasty (PK) for treatingcorneal disordersthat do not involve theendothelium. DALK preserves the host endothelium, eliminating the risk of endothelial rejection and reducing the risk of late graft failure due to endothelial decay. Despite its not recent introduction, DALK has been considered a difficult, lengthy, and poorly reproducible procedure, limiting its adoption worldwide. With the introduction of the big-bubble technique (BBT) the reproducibility and the time required to complete the procedure were significantly improved, encouraging many surgeons to approach DALK. With BBT air is injected into the stroma to induce separation between the layers of the cornea, facilitating the separation of the diseased or scarred stroma from the healthy endothelium; this allows the creation of a graft-host interface of pristine optical quality, granting clinical results equal to those obtained with PK.Understanding the anatomy and physics behind the big bubble (BB) formation is crucial for thesurgical success of this technique. The discovery of the pre-Descemet's layer (Dua's layer)played a significant role in understanding the principles behindBBformation, considerablyimpacting the safety and reproducibility of the technique. BB formation is influenced by preoperative pathology, trephination size, and instruments used for air injection.Continue advancements have helped to refine BBT's efficacy and reproducibility, broadening its applicability in corneal transplantation whenever the endothelium is healthy.This review provides a detailed account of the procedural steps involved in DALK using the BBT, addressing the most common challenges, highlightingtechnical innovations, and handlingthe most frequent complications.
深前片状角膜移植术(DALK)被认为是穿透性角膜移植术(PK)的一种重要替代方法,可用于治疗不涉及内皮的角膜疾病。DALK 保留了宿主内皮,消除了内皮排斥的风险,并降低了因内皮衰变而导致后期移植物失败的风险。尽管 DALK 术问世时间不长,但一直被认为是一种难度大、时间长、可重复性差的手术,这限制了它在全球范围内的应用。随着大气泡技术(BBT)的引入,可重复性和完成手术所需的时间都得到了显著改善,鼓励了许多外科医生采用 DALK。大气泡技术将空气注入角膜基质层,诱导角膜层间分离,促进病变或瘢痕角膜基质层与健康角膜内皮层的分离;这样就能创造出具有原始光学质量的移植物-宿主界面,获得与 PK 技术相同的临床效果。前戴斯麦层(Dua层)的发现对了解大泡形成背后的原理起到了重要作用,极大地影响了该技术的安全性和可重复性。BBT的形成受术前病理、切削大小和注入空气所用器械的影响。不断的进步帮助完善了BBT的疗效和可重复性,扩大了其在角膜移植中的适用范围,只要角膜内皮是健康的。本综述详细介绍了使用BBT进行DALK的手术步骤,解决了最常见的难题,突出了技术创新,并处理了最常见的并发症。
{"title":"Big-bubble DALK: A technique in evolution","authors":"Antonio Moramarco ,&nbsp;Lorenzo Gardini ,&nbsp;Ilaria Di Mola ,&nbsp;Natalie di Geronimo ,&nbsp;Danilo Iannetta ,&nbsp;Vito Romano ,&nbsp;Sadeer B. Hannush ,&nbsp;Luigi Fontana","doi":"10.1016/j.jtos.2024.10.001","DOIUrl":"10.1016/j.jtos.2024.10.001","url":null,"abstract":"<div><div>Deep anterior lamellar keratoplasty (DALK) is considered a valuablealternative to penetrating keratoplasty (PK) for treatingcorneal disordersthat do not involve theendothelium. DALK preserves the host endothelium, eliminating the risk of endothelial rejection and reducing the risk of late graft failure due to endothelial decay. Despite its not recent introduction, DALK has been considered a difficult, lengthy, and poorly reproducible procedure, limiting its adoption worldwide. With the introduction of the big-bubble technique (BBT) the reproducibility and the time required to complete the procedure were significantly improved, encouraging many surgeons to approach DALK. With BBT air is injected into the stroma to induce separation between the layers of the cornea, facilitating the separation of the diseased or scarred stroma from the healthy endothelium; this allows the creation of a graft-host interface of pristine optical quality, granting clinical results equal to those obtained with PK.Understanding the anatomy and physics behind the big bubble (BB) formation is crucial for thesurgical success of this technique. The discovery of the pre-Descemet's layer (Dua's layer)played a significant role in understanding the principles behindBBformation, considerablyimpacting the safety and reproducibility of the technique. BB formation is influenced by preoperative pathology, trephination size, and instruments used for air injection.Continue advancements have helped to refine BBT's efficacy and reproducibility, broadening its applicability in corneal transplantation whenever the endothelium is healthy.This review provides a detailed account of the procedural steps involved in DALK using the BBT, addressing the most common challenges, highlightingtechnical innovations, and handlingthe most frequent complications.</div></div>","PeriodicalId":54691,"journal":{"name":"Ocular Surface","volume":"34 ","pages":"Pages 418-429"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142383137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ocular Surface
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1